Latest Breaking News On - Phore limited - Page 1 : vimarsana.com

NeoPhore closes oversubscribed Series B extension round with additional funding from Bristol Myers Squibb

Additional funding will be used to explore novel biology around the MMR pathway and accelerate progression of the lead program into candidate selectionLONDON, May 22, 2024 /PRNewswire/ NeoPhore

City ofUnited kingdomMatthew bakerBristol myers squibbRobert jamesPhoremost ltdPioneer fundNeophore ltdBristol myers squibb companyPrnewswire neophoreUniversity of turinPhore limitedChief executive officerMyers squibbIhr portfolio

NeoPhore signs research collaboration with The Institute of Cancer Research, London

/PRNewswire/ NeoPhore Limited, a small molecule neoantigen immuno-oncology company, today announces that it has signed a strategic collaboration agreement.

United kingdomCity ofMatthew bakerInstitute of cancer researchUniversity of turinDrug development unitPioneer fundUniversity of londonMemorial sloan kettering cancer centerSt george university of londonCancer research united kingdom gene function teamPhoremost ltdNeophore ltdPrnewswire neophoreCentre for cancer drug discoveryPhore limited

Tech Transfer Roundup: Erasca Calls On MD Anderson To Advance Its RAS/MAPK Pipeline

Tech Transfer Roundup: Erasca Calls On MD Anderson To Advance Its RAS/MAPK Pipeline
informa.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from informa.com Daily Mail and Mail on Sunday newspapers.

United statesEteläuomen läiUnited kingdomSosei heptaresUniversity of californiaSosei team up on immunotherapy trialGlobal health drug discovery instituteBerkeley translational chemical biology instituteHuayi health drug discovery instituteUniversity of marylandMelinda gates foundationE continues partnership withRoivant taps research labsBriacell therapeutics corpInhibitor researchTsinghua university

Weekly Pharma & Life Sciences News Round-Up: 25th – 29th July

A round-up of the latest news from the Life Science industry; including news from the Pharmaceutical, Clinical Research, Biotechnology and Medical Device sectors from 25th-29th July .

New yorkUnited statesMemorial sloan kettering cancer centerUnited kingdomEteläuomen läiBlaenau gwentMichael stalhamerPhilipp kolbAsia pacificUniversity of freiburgPleco therapeutics united states incClinical researchPrecipoint group gmbClinical developmentRegeneron pharmaceuticals incUniversity of helsinki

NeoPhore Enters Three Year Research Collaboration with World Leading Oncologist s Lab at Major US Cancer Center

CAMBRIDGE, England, July 28, 2022 /PRNewswire/ NeoPhore Limited, a small molecule neoantigen immuno-oncology company, today announces that it has entered a three-year research collaboration

New yorkUnited statesMemorial sloan kettering cancer centerUnited kingdomMatthew bakerKostenloser wertpapierhandelNeophore ltdPrnewswire neophorePhoremost ltdUniversity of turinPioneer fundPhore limitedChief executive officer